Coffee Consumption and Risk of Cardiovascular Diseases and All-Cause Mortality Among Men With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Coffee consumption has been linked to detrimental acute metabolic and hemodynamic effects. We investigated coffee consumption in relation to risk of CVDs and mortality in diabetic men. RESEARCH DESIGN AND METHODS: We conducted a prospective cohort study including 3,497 diabetic men without CVD at baseline. RESULTS: After adjustment for age, smoking, and other cardiovascular risk factors, relative risks (RRs) were 0.88 (95% CI 0.50–1.57) for CVDs (P for trend = 0.29) and 0.80 (0.41–1.54) for all-cause mortality (P for trend = 0.45) for the consumption of ≥4 cups/day of caffeinated coffee compared with those for non–coffee drinkers. Stratification by smoking and duration of diabetes yielded similar results. RRs for caffeine intake for the highest compared with the lowest quintile were 1.02 (0.70–1.47; P for trend = 0.96) for CVDs and 0.96 (0.64–1.44; P for trend = 0.69) for mortality. CONCLUSIONS: These data indicate that regular coffee consumption is not associated with increased risk for CVDs or mortality in diabetic men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feskanich, D., Rimm, E. B., Giovannucci, E. L., Colditz, G. A., Stampfer, M. J., Litin, L. B., & Willett, W. C. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91754-e · Cited by 1,070 · cited 1×
“The validity and reliability of the FFQ has been previously described [6].”
BackgroundTolerance to the humoral and hemodynamic effects of caffeine in man.
Robertson, D., Wade, D., Workman, R., Woosley, R. L., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110124 · Cited by 501 · cited 1×
“Second, the acute effects of caffeine could be transient because partial tolerance to the humoral and hemodynamic effects of caffeine among habitual drinkers might develop after several days of use (14).”
BackgroundCoffee consumption and risk for type 2 diabetes mellitus
Salazar-Martinez, E., Willett, W. C., Ascherio, A., Manson, J. E., Leitzmann, M. F., Stampfer, M. J., & Hu, F. B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00005 · Cited by 462 · cited 1×
“We also assessed total caffeine intake [7].”
Self-citationMetabolic and exercise endurance effects of coffee and caffeine ingestion
Graham, T. E., Hibbert, E., & Sathasivam, P. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.3.883 · Cited by 305 · cited 1×
“It has been shown that caffeine results in a larger increase in epinephrine concentrations than intake of the same amount of caffeine in coffee [12].”
Coffee Consumption and Coronary Heart Disease in Men and Women: A Prospective Cohort Study
Lopez-Garcia, E., van Dam, R. M., Willett, W. C., Rimm, E. B., Manson, J. E., Stampfer, M. J., Rexrode, K. M., & Hu, F. B. (2006) · Circulation · doi:10.1161/circulationaha.105.598664 · Cited by 215 · cited 2×
“Whereas most prospective studies have suggested that coffee consumption is not associated with increased risk for cardiovascular disease in general population [3,4], data among diabetes are sparse[5].”
BackgroundMethodSelf-citationCardiovascular effects of caffeine in men and women
Hartley, T. R., Lovallo, W. R., & Whitsett, T. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.057 · Cited by 168
Verhoef, P., Pasman, W. J., van Vliet, T., Urgert, R., & Katan, M. B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1244 · Cited by 158 · cited 1×
“In addition, concerns have been raised in short-term trials that caffeine increases blood pressure [10] and homocysteine levels [11].”
BackgroundBidel, S., Hu, G., Qiao, Q., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2006) · Diabetologia · doi:10.1007/s00125-006-0435-9 · Cited by 107
Lane, J. D., Feinglos, M. N., & Surwit, R. S. (2008) · Diabetes Care · doi:10.2337/dc07-1112 · Cited by 62
Cited by
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613
A review on the beneficial aspects of food processing
van Boekel, M., Fogliano, V., Pellegrini, N., Stanton, C., Scholz, G., Lalljie, S., Somoza, V., Knorr, D., Jasti, P. R., & Eisenbrand, G. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900608 · Cited by 555
Caffeine and cardiovascular health
Turnbull, D., Rodricks, J. V., Mariano, G. F., & Chowdhury, F. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.07.025 · Cited by 216
Malerba, S., Turati, F., Galeone, C., Pelucchi, C., Verga, F., La Vecchia, C., & Tavani, A. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9834-7 · Cited by 119
“Among favorable effects on CVD risk, coffee decreased the risk of diabetes incidence[2] and might decrease CVD risk in diabetic patients [64, 65].”
Background
Metadata
- Authors
- Zhang, W., Lopez-Garcia, E., Li, T. Y., Hu, F. B., & van Dam, R. M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-02-19
- Volume
- 32
- Issue
- 6
- Pages
- 1043-1045
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2118480730
- Cited by
- 60
- References
- 9
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.